Astria Therapeutics, Inc. (ATXS)
12.95
-0.04
(-0.31%)
USD |
NASDAQ |
Dec 30, 14:12
Astria Therapeutics Market Cap: 739.25M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.600B |
| Hologic, Inc. | 16.61B |
| Johnson & Johnson | 499.13B |
| Alnylam Pharmaceuticals, Inc. | 52.41B |
| CorMedix, Inc. | 996.68M |
Market Cap Related Metrics
| PS Ratio | 1056.78 |
| PEG Ratio | -2.204 |
| Price to Book Value | 5.360 |
| Price | 12.95 |
| Earnings Yield | -16.61% |
| PEGY Ratio | -2.204 |